As 2023 comes to a close, let’s take a look back at this year’s top patent decisions. Patent litigation had an active year with many important cases in contention for the top spots. These five decisions changed the legal landscape. From life sciences to industrial designs to trade shows, these decisions spanned a wide variety of patent law issues and signal that Constitutional patent rights are still exploring new legal questions and breaking new ground almost 250 years after our nation’s founding.

‘Amgen v. Sanofi,’ 598 U.S. 594 (2023)

The one and only patent case from the 2022-2023 term, the U.S. Supreme Court’s Amgen decision on patent enablement was widely watched across the biotechnology, chemical and pharmaceutical industries.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]